ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 91 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,000 | -85.5% | 14,993 | -71.0% | 0.00% | – |
| Q3 2018 | $110,000 | +233.3% | 51,747 | +266.0% | 0.00% | – |
| Q2 2018 | $33,000 | -88.3% | 14,139 | -84.1% | 0.00% | – |
| Q1 2018 | $282,000 | -25.0% | 88,749 | -21.3% | 0.00% | – |
| Q2 2017 | $376,000 | -73.8% | 112,824 | -27.5% | 0.00% | – |
| Q1 2017 | $1,435,000 | +48.4% | 155,702 | +24.1% | 0.00% | – |
| Q4 2016 | $967,000 | -13.6% | 125,458 | +28.1% | 0.00% | – |
| Q3 2016 | $1,119,000 | +40.6% | 97,900 | +51.3% | 0.00% | – |
| Q2 2016 | $796,000 | -22.4% | 64,700 | -36.2% | 0.00% | – |
| Q1 2016 | $1,026,000 | -60.7% | 101,400 | -12.5% | 0.00% | – |
| Q4 2015 | $2,612,000 | -6.3% | 115,857 | -31.0% | 0.00% | -100.0% |
| Q3 2015 | $2,787,000 | +1.8% | 167,982 | +38.0% | 0.00% | 0.0% |
| Q2 2015 | $2,739,000 | +42.7% | 121,685 | +63.5% | 0.00% | – |
| Q1 2015 | $1,919,000 | +372.7% | 74,404 | +298.6% | 0.00% | – |
| Q4 2014 | $406,000 | -77.2% | 18,668 | -80.2% | 0.00% | -100.0% |
| Q3 2014 | $1,781,000 | – | 94,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|